Bottom line
IHI vs RYHIX: the short answer
IHI (iShares U.S. Medical Devices ETF) and RYHIX (Health Care Fund) are quite different portfolios: only about 16% of their top holdings (by weight) are shared.
But RYHIX is far broader, holding 135 positions to 50 for IHI, so beyond the top names it adds exposure IHI doesn't have.
IHI is cheaper at 0.37% vs 1.38% — a difference of $101 a year per $10,000 invested.
Over five years, RYHIX returned +5.1% a year vs +3.1% for IHI.
Updated Nov 19, 2026
IHI vs RYHIX side by side
| IHI | RYHIX | |
|---|---|---|
| Type | ETF | Mutual fund |
| Fund family | iShares | Guggenheim |
| Category | Health Care Sector | Health Care Sector |
| Expense ratio | 0.37% | 1.38% |
| Annual cost per $10k | $37 | $138 |
| 10-yr cost on $10k (prospectus) | $468 | $1,709 |
| Max front load | None | — |
| 12b-1 fee | 0% | 0% |
| 1-yr return | +6.9% | +14.4% |
| 5-yr return (annualized) | +3.1% | +5.1% |
| 10-yr return (annualized) | +12.2% | +7.9% |
| Best quarter | +17.6% | +18.7% |
| Worst quarter | −17.2% | −14.4% |
| Net assets (fund) | $3.0B | $19.4M |
| Number of holdings | 50 | 135 |
| Portfolio turnover | 12% | 244% |
| Returns as of | Dec 31, 2025 | Dec 31, 2025 |
Source: SEC Form N-PORT and fund prospectuses
Year-by-year returns
| Year | IHI | RYHIX | Difference |
|---|---|---|---|
| 2025 | +6.9% | +14.4% | −7.6% |
| 2024 | +8.6% | +0.6% | +8.0% |
| 2023 | +3.2% | +5.8% | −2.6% |
| 2022 | −19.7% | −11.6% | −8.1% |
| 2021 | +21.0% | +19.2% | +1.8% |
| 2020 | +24.2% | +18.9% | +5.2% |
| 2019 | +32.7% | +22.8% | +9.9% |
| 2018 | +15.5% | +1.6% | +13.9% |
| 2017 | +30.9% | +23.5% | +7.5% |
| 2016 | +9.2% | −9.4% | +18.5% |
Source: Fund prospectus bar charts
Holdings overlap
5 of IHI's top 25 holdings also appear in RYHIX's top 25.
| Holding | IHI | RYHIX |
|---|---|---|
| Abbott Laboratories | 16.93% | 1.42% |
| Intuitive Surgical, Inc. | 15.09% | 1.31% |
| Stryker Corporation | 11.64% | 1.21% |
| Edwards Lifesciences Corporation | 4.75% | 0.84% |
| Boston Scientific Corporation | 3.99% | 0.86% |
Source: SEC Form N-PORT
IHI top 10
- Abbott Laboratories — 16.93%
- Intuitive Surgical, Inc. — 15.09%
- Stryker Corporation — 11.64%
- Edwards Lifesciences Corporation — 4.75%
- Becton, Dickinson And Company — 4.63%
- Ge Healthcare Technologies Inc. — 4.51%
- Medtronic Public Limited Company — 4.40%
- Resmed Inc. — 4.38%
- Idexx Laboratories, Inc. — 4.27%
- Dexcom, Inc. — 4.02%
RYHIX top 10
- Eli Lilly & Company — 3.63%
- Johnson & Johnson — 2.88%
- Abbvie Inc — 2.52%
- Unitedhealth Group Inc — 2.22%
- Merck & Company Inc — 2.04%
- Thermo Fisher Scientific Inc — 1.61%
- Amgen Inc — 1.56%
- Abbott Laboratories — 1.42%
- Gilead Sciences Inc — 1.39%
- Vertex Pharmaceuticals Inc — 1.34%
FAQ
What is the difference between IHI and RYHIX?
Which is cheaper, IHI or RYHIX?
Should I own both IHI and RYHIX?
Educational comparison based on public filings; not investment advice. Past performance does not guarantee future results.